APOH and systemic lupus erythematosus: Patients with SLE may have antiphospholipid antibodies (aPLs), including anti‐β2‐glycoprotein I (β2GPI) antibody, anticardiolipin (aCL) antibody, and lupus anticoagulant (Petri et al., 2012).